UK Drug Pricing & IP Targeted As US Gears Up For Post-Brexit Trade Deal Talks

 
• By Ian Schofield

The US has published its final negotiating objectives for a post-Brexit trade deal with the UK, which include pushing for stronger IP protections and changes to UK processes for patient access to new drugs.

WavingFlags
The UK and US are preparing to negotiate a post-Brexit trade deal • Source: Shutterstock

More from United Kingdom

More from Europe